Home/Filings/4/0001209191-23-021919
4//SEC Filing

Hull Hans 4

Accession 0001209191-23-021919

CIK 0001746473other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 5:59 PM ET

Size

9.0 KB

Accession

0001209191-23-021919

Insider Transaction Report

Form 4
Period: 2023-03-29
Hull Hans
Chief Business Officer
Transactions
  • Award

    Common Stock

    2023-03-29+17,578211,000 total
Holdings
  • Common Stock

    (indirect: See footnote)
    13,985
  • Common Stock

    (indirect: See footnote)
    13,985
  • Common Stock

    (indirect: See footnote)
    3,821
Footnotes (5)
  • [F1]On July 28, 2022, the Reporting Person was granted 70,313 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On March 29,2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 17,578 shares.
  • [F2]Includes 1,231 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
  • [F3]The shares are held by The Sloger Hull Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.
  • [F4]The shares are held by a trust for the Reporting Person's minor child ("Child A Trust"). The Reporting Person and his spouse serve as trustees for Child A Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F5]The shares are held by a trust for the Reporting Person's minor child ("Child B Trust"). The Reporting Person and his spouse serve as trustees for Child B Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001614876

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 5:59 PM ET
Size
9.0 KB